Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Dow
QuintilesIMS
McKesson
US Department of Justice
Boehringer Ingelheim
Daiichi Sankyo
Mallinckrodt
Healthtrust
Julphar

Generated: October 19, 2018

DrugPatentWatch Database Preview

SODIUM NITRITE Drug Profile

« Back to Dashboard

Which patents cover Sodium Nitrite, and when can generic versions of Sodium Nitrite launch?

Sodium Nitrite is a drug marketed by Hope Pharms and is included in one NDA. There is one patent protecting this drug.

The generic ingredient in SODIUM NITRITE is sodium nitrite. There are one thousand four hundred and fifty-four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the sodium nitrite profile page.

Drug patent expirations by year for SODIUM NITRITE
Medical Subject Heading (MeSH) Categories for SODIUM NITRITE
Synonyms for SODIUM NITRITE
32863-15-3
56227-20-4
7632-00-0
82497-43-6
82998-40-1
AC1Q1VAY
AC1Q4THG
AKOS024427981
Anti-rust
ANW-36776
Azotyn sodowy
Azotyn sodowy [Polish]
CAS-7632-00-0
Caswell No. 782
CCRIS 559
CHEBI:78870
CHEMBL93268
CTK2H7764
D05865
DB09112
diazoting salts
Diazotizing salts
DSSTox_CID_941
DSSTox_GSID_20941
DSSTox_RID_75879
DTXSID0020941
Dusitan sodny [Czech]
E250
EINECS 231-555-9
EPA Pesticide Chemical Code 076204
Erinitrit
Filmerine
FT-0645124
HMS3652K08
HSDB 757
I14-90844
IN002039
IN018365
KB-60553
KS-00000WUJ
KSC377O6J
LPXPTNMVRIOKMN-UHFFFAOYSA-M
M0KG633D4F
MFCD00011118
MolPort-003-926-309
NaNO2
Natrium nitrit
Natrium nitrit [German]
natrium nitrite
NCGC00090737-01
NCGC00090737-02
NCGC00254137-01
NCGC00259704-01
NCI-C02084
Nitrite de sodium
Nitrite de sodium [French]
Nitrite ion standard solution
Nitrite ion standard solution, 0.01 M NO2-, for ion-selective electrodes
Nitrite ion standard solution, 0.1 M NO2-, for ion-selective electrodes
Nitrite, sodium
Nitrito sodico
Nitrito sodico [Spanish]
Nitrous acid, sodium salt
Nitrous acid, sodium salt (1:1)
NITROUS-15NACID, SODIUM SALT (9CI)
NNaO2
NSC 77391
RP18285
RTR-037707
S0565
s209
s4074
SC-46815
sodium nitrit
Sodium nitrite (TN)
Sodium nitrite (USP)
Sodium nitrite [UN1500] [Oxidizer]
Sodium nitrite [UN1500] [Oxidizer]
Sodium Nitrite [USAN]
Sodium nitrite [USP]
Sodium nitrite solution
Sodium nitrite solution, 40 wt. % in H2O
Sodium nitrite, >=99.99% trace metals basis
Sodium nitrite, 0.1M Standardized Solution
Sodium nitrite, 99.5%, super free-flowing
Sodium nitrite, 99.999% trace metals basis
Sodium nitrite, ACS reagent, >=97.0%
Sodium nitrite, ACS, 97.0% min. 25g
Sodium nitrite, analytical standard
Sodium nitrite, anhydrous, free-flowing, Redi-Dri(TM), ACS reagent, >=97%
Sodium nitrite, AR, >=98%
Sodium nitrite, granular, 99.5%
Sodium nitrite, JIS special grade, >=98.5%
Sodium nitrite, LR, >=98%
Sodium nitrite, p.a., ACS reagent, 99%
Sodium nitrite, puriss. p.a., ACS reagent, >=99.0% (RT)
Sodium nitrite, puriss. p.a., ACS reagent, reag. Ph. Eur., >=99%
Sodium nitrite, puriss., meets analytical specification of Ph. Eur., BP, USP, FCC, E 250, 99-100.5% (calc. to the dried substance)
Sodium nitrite, purum p.a., >=98.0% (RT)
Sodium nitrite, ReagentPlus(R), >=99.0%
Sodium nitrite, SAJ first grade, >=97.0%
Sodium nitrite, United States Pharmacopeia (USP) Reference Standard
Sodium nitrite,food grade
sodium-nitrite
sodiumnitrite
Synfat 1004
Tox21_202155
Tox21_300025
TR-037707
TRA0042859
UN1500
UNII-M0KG633D4F

US Patents and Regulatory Information for SODIUM NITRITE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hope Pharms SODIUM NITRITE sodium nitrite SOLUTION;INTRAVENOUS 203922-001 Feb 14, 2012 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Hope Pharms SODIUM NITRITE sodium nitrite SOLUTION;INTRAVENOUS 203922-001 Feb 14, 2012 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for SODIUM NITRITE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0052 France ➤ Sign Up PRODUCT NAME: SUGAMMADEX SODIUM; REGISTRATION NO/DATE: EU/1/08/466/001-002 20080725
C/GB06/021 United Kingdom ➤ Sign Up PRODUCT NAME: PEGAPTANIB, PREFERABLY IN THE FORM OF ITS SODIUM SALT; REGISTERED: UK EU/1/05/325/001 20060201
C/GB98/025 United Kingdom ➤ Sign Up PRODUCT NAME: MONTELUKAST, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREFERABLY MONTELUKAST SODIUM; REGISTERED: FI 12766 19970825; FI 12767 19970825; UK 00025/0357 19980115; UK 00025/0358 19980115
14/032 Ireland ➤ Sign Up PRODUCT NAME: DOLUTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF, INCLUDING DOLUTEGRAVIR SODIUM; REGISTRATION NO/DATE: EU/1/13/892/001-002 20140121
90064-1 Sweden ➤ Sign Up PRODUCT NAME: SIMEPREVIR, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516
99C0030 Belgium ➤ Sign Up PRODUCT NAME: RABEPRAZOLE SODIUM; NAT. REGISTRATION NO/DATE: 5532 IE 1 F 3 19990201; FIRST REGISTRATION: GB 10555/0010 19980508
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
QuintilesIMS
McKesson
US Department of Justice
Boehringer Ingelheim
Daiichi Sankyo
Mallinckrodt
Healthtrust
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.